Vivus says victim of false statements, delays shareholder meet
(Reuters) - U.S. drugmaker Vivus Inc, locked in a proxy battle with top investor First Manhattan Co, said FMC's advisers had made false statements to its shareholders and that it would delay its annual meeting by three days to allow FMC to make corrections. Vivus said on Sunday that the statements related the recommendation provided by proxy advisory firm Institutional Shareholder Services (ISS) but did not provide details. ISS backed three of the nine nominees put forward by FMC but said the wholesale changes that FMC demanded at the company were not required. Vivus said it had asked the U.S. ...
You May Also Like...
http://facelover.ir/index.php?do=/blog/1143/practical-suggestions-on-using-any-weight-loss-supplements/add-comment/
http://fowop.com/content/Values-Using-Effective-Weight-Loss-Pills
http://arklab.ucalgary.ca/groups/arky423ahistoricaloverviewofeitherthefifththuleexpeditionorthecanadianarcticexpedition/wiki/3fc56/Essential_Information_About_All_Natural_Slimming_Supplements.html
http://aroundhamptonroads.com/blogs/924/831/why-do-you-need-natural-slimming
http://agcsb.com/index.php?do=/blog/13535/essential-information-regarding-effective-slimming-pills/add-comment/
http://amrilulanah.xanga.com/773397429/how-do-i-cut-weight/
No comments:
Post a Comment